China is rapidly overtaking the US in global oncology clinical trials, accounting for more than half of late-stage study activity by 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results